- Last traded
- 22 Dec 2025
- Last close
- 0.08p
- Market cap at last close
- £966k
| 15 Dec 2025 | 16:03:49 | Result of General Meeting |
| 1 Dec 2025 | 07:00:13 | Chest coil passes Philips compatibility testing |
| 25 Nov 2025 | 07:00:21 | First Xenon Hyperpolariser in Asia |
| 24 Nov 2025 | 07:00:04 | Korean distributor agreement with DK Healthcare |
| 14 Nov 2025 | 07:00:08 | Proposed Cancellation of Admission & Notice of GM |
| 2 Oct 2026 | Annual Report and Accounts (to 2025-12-31) | |
| 15 May 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 9 Jul 2024 | Annual Report and Accounts (to 2023-12-31) |
Polarean Imaging PLC develops and manufactures drug-device systems for medical imaging, specifically focusing on noble gas hyperpolariser devices and its proprietary $^{125}\mathrm{Xe}$ drug. The company provides services related to pulmonary imaging and operates in the healthcare sector, targeting hospitals and research institutions. Its activities include research and development, often in collaboration with academic partners, to enhance imaging technology and meet market demands. Polarean Imaging operates primarily in the United States and is committed to advancing its imaging capabilities through ongoing innovation.
| 15 Dec 2025 | 16:03:49 | Result of General Meeting |
| 1 Dec 2025 | 07:00:13 | Chest coil passes Philips compatibility testing |
| 25 Nov 2025 | 07:00:21 | First Xenon Hyperpolariser in Asia |
| 24 Nov 2025 | 07:00:04 | Korean distributor agreement with DK Healthcare |
| 14 Nov 2025 | 07:00:08 | Proposed Cancellation of Admission & Notice of GM |
| 2 Oct 2026 | Annual Report and Accounts (to 2025-12-31) | |
| 15 May 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 9 Jul 2024 | Annual Report and Accounts (to 2023-12-31) |
Polarean Imaging PLC develops and manufactures drug-device systems for medical imaging, specifically focusing on noble gas hyperpolariser devices and its proprietary $^{125}\mathrm{Xe}$ drug. The company provides services related to pulmonary imaging and operates in the healthcare sector, targeting hospitals and research institutions. Its activities include research and development, often in collaboration with academic partners, to enhance imaging technology and meet market demands. Polarean Imaging operates primarily in the United States and is committed to advancing its imaging capabilities through ongoing innovation.